INVIVO ANTITUMOR-ACTIVITY OF TUMOR-INFILTRATING LYMPHOCYTES EXPANDED IN RECOMBINANT INTERLEUKIN-2

被引:1
|
作者
SPIESS, PJ [1 ]
YANG, JC [1 ]
ROSENBERG, SA [1 ]
机构
[1] US PHS, NCI,DIV CANC TREATMENT,SURG BRANCH,BLDG 10, ROOM 2B44, BETHESDA, MD 20892 USA
来源
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1067 / 1075
页数:9
相关论文
共 50 条
  • [31] Repression of interleukin-2 mRNA translation in primary human breast carcinoma tumor-infiltrating lymphocytes
    Lopez, CB
    Rao, TD
    Feiner, H
    Shapiro, R
    Marks, JR
    Frey, AB
    CELLULAR IMMUNOLOGY, 1998, 190 (02) : 141 - 155
  • [32] TREATMENT OF MURINE PRIMARY BRAIN-TUMORS WITH SYSTEMIC INTERLEUKIN-2 AND TUMOR-INFILTRATING LYMPHOCYTES
    SARIS, SC
    SPIESS, P
    LIEBERMAN, DM
    LIN, S
    WALBRIDGE, S
    OLDFIELD, EH
    JOURNAL OF NEUROSURGERY, 1992, 76 (03) : 513 - 519
  • [33] PROLIFERATIVE, PHENOTYPIC AND FUNCTIONAL AND MOLECULAR CHARACTERISTICS OF TUMOR-INFILTRATING LYMPHOCYTES OBTAINED FROM UNSELECTED PATIENTS WITH MALIGNANT MELANOMAS AND EXPANDED IN-VITRO IN THE PRESENCE OF RECOMBINANT INTERLEUKIN-2
    MELIOLI, G
    GUASTELLA, M
    SEMINO, C
    META, M
    PIETRA, G
    PONTE, M
    QUEIROLO, P
    SERTOLI, MR
    MARTINI, L
    REALI, UM
    MELANOMA RESEARCH, 1994, 4 (02) : 127 - 133
  • [34] THE PROMOTIVE EFFECT OF INTERLEUKIN-4 WITH INTERLEUKIN-2 IN THE PROLIFERATION OF TUMOR-INFILTRATING LYMPHOCYTES FROM PATIENTS WITH MALIGNANT-TUMOR
    TSUNODA, T
    TANIMURA, H
    YAMAUE, H
    IWAHASHI, M
    TANI, M
    TAMAI, M
    ARII, K
    NOGUCHI, K
    BIOTHERAPY, 1992, 4 (01) : 9 - 15
  • [35] Efficacy of adoptive therapy with tumor-infiltrating lymphocytes and recombinant interleukin-2 in advanced cutaneous melanoma: a systematic review and meta-analysis
    Dafni, U.
    Michielin, O.
    Lluesma, S. Martin
    Tsourti, Z.
    Polydoropoulou, V.
    Karlis, D.
    Besser, M. J.
    Haanen, J.
    Svane, I. -M.
    Ohashi, P. S.
    Kammula, U. S.
    Orcurto, A.
    Zimmermann, S.
    Trueb, L.
    Klebanoff, C. A.
    Lotze, M. T.
    Kandalaft, L. E.
    Coukos, G.
    ANNALS OF ONCOLOGY, 2019, 30 (12) : 1902 - 1913
  • [36] TUMOR INFILTRATING LYMPHOCYTES AND CONTINUOUS INFUSION RECOMBINANT INTERLEUKIN-2 IN RENAL-CELL CARCINOMA
    MURTHY, S
    FINKE, J
    TUBBS, R
    SHARFMAN, W
    ALEXANDER, J
    RAYMOND, P
    SERGI, J
    BUKOWSKI, R
    JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, 1989, 8 (03): : 306 - 306
  • [37] CLINICAL-RESULTS AND CHARACTERIZATION OF TUMOR-INFILTRATING LYMPHOCYTES WITH OR WITHOUT RECOMBINANT INTERLEUKIN-2 IN HUMAN METASTATIC RENAL-CELL CARCINOMA
    BUKOWSKI, RM
    SHARFMAN, W
    MURTHY, S
    RAYMAN, P
    TUBBS, R
    ALEXANDER, J
    BUDD, GT
    SERGI, JS
    BAUER, L
    GIBSON, V
    STANLEY, J
    BOYETT, J
    PONTES, E
    FINKE, J
    CANCER RESEARCH, 1991, 51 (16) : 4199 - 4205
  • [38] INTRAPERITONEAL ADOPTIVE IMMUNOTHERAPY OF OVARIAN-CARCINOMA WITH TUMOR-INFILTRATING LYMPHOCYTES AND LOW-DOSE RECOMBINANT INTERLEUKIN-2 - A PILOT TRIAL
    FREEDMAN, RS
    EDWARDS, CL
    KAVANAGH, JJ
    KUDELKA, AP
    KATZ, RL
    CARRASCO, CH
    ATKINSON, EN
    SCOTT, W
    TOMASOVIC, B
    TEMPLIN, S
    PLATSOUCAS, CD
    JOURNAL OF IMMUNOTHERAPY, 1994, 16 (03): : 198 - 210
  • [39] IN-VITRO PREDICTORS OF THERAPEUTIC RESPONSE IN MELANOMA PATIENTS RECEIVING TUMOR-INFILTRATING LYMPHOCYTES AND INTERLEUKIN-2
    SCHWARTZENTRUBER, DJ
    HOM, SS
    DADMARZ, R
    WHITE, DE
    YANNELLI, JR
    STEINBERG, SM
    ROSENBERG, SA
    TOPALIAN, SL
    JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (07) : 1475 - 1483
  • [40] USE OF TUMOR-INFILTRATING LYMPHOCYTES AND INTERLEUKIN-2 IN THE IMMUNOTHERAPY OF PATIENTS WITH METASTATIC MELANOMA - A PRELIMINARY-REPORT
    ROSENBERG, SA
    PACKARD, BS
    AEBERSOLD, PM
    SOLOMON, D
    TOPALIAN, SL
    TOY, ST
    SIMON, P
    LOTZE, MT
    YANG, JC
    SEIPP, CA
    SIMPSON, C
    CARTER, C
    BOCK, S
    SCHWARTZENTRUBER, D
    WEI, JP
    WHITE, DE
    NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (25): : 1676 - 1680